Clinical Trials

Below are current clinical trials.


3 studies in Eye melanoma
(open studies only).

Filter this list of studies by location, status and more.

  1. Melanocytic Lesion Blood and Tissue Bank and Database

    La Crosse, Wis., Scottsdale/Phoenix, Ariz., Jacksonville, Fla., Rochester, Minn.

    This study is being done to collect patient data and samples (blood, plasma and tissue) for future research on melanoma.

  2. Two Cancers, One Gene. Why Some People in Families Develop Melanoma or Pancreas Cancer, While Still Others Never Develop Cancer.

    Rochester, Minn.

    Individuals who are affected with pancreas cancer and melanoma as well as those without either cancer who have been identified as 1st or 2nd degree relatives of family members with pancreas cancer and melanoma will be asked to participate. The participant will be asked to complete a survey about their health and family history of cancer and to give a blood sample for specific gene testing and storage for future research studies.The overall goal of this study is to understand the factors that increase susceptibility and expression of pancreatic cancer and melanoma in high risk families.

  3. Glembatumumab Vedotin in Treating Patients With Metastatic or Locally Recurrent Uveal Melanoma

    Scottsdale/Phoenix, Ariz., Jacksonville, Fla., Rochester, Minn.

    This phase II trial studies how well glembatumumab vedotin works in treating patients with middle layer of the wall of the eye (uveal) melanoma that has spread to other parts of the body (metastatic) or has returned at or near the same place after a period of time during which the cancer could not be detected (locally recurrent). Glembatumumab vedotin may shrink the tumor by binding to tumor cells and delivering tumor-killing substances to them.

July 22, 2015